Company / Cost of Revenue
Penumbra, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$461.2M
FY2025
5-year range
$175.4M / $461.2M
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#65 of 113
Health Care
What the data says
At $461M, Penumbra, Inc.'s cost of revenue ranks #49 of 113 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $175M in FY2021 to $461M in FY2025.
Based on SEC 10-K filings.
$461M in FY2025 with a 5-year CAGR of +15.7%.
Increased from $376M to $461M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
#49 of 113 in Health CareTop 42% of 113This company $461.2M Sector average $11.3B
▼
-95.9% below sector average
Key checks
Key Insights
- Penumbra, Inc.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +15.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 4.9% year-over-year.
- Ranks #65 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $461.2M | +4.9% |
| FY2024 | $439.6M | +17.0% |
| FY2023 | $375.9M | +69.1% |
| FY2022 | $222.2M | +26.7% |
| FY2021 | $175.4M | -21.1% |
| FY2020 | $222.2M | +90.6% |
| FY2019 | $116.6M | +26.1% |
| FY2018 | $92.5M | +49.1% |
| FY2017 | $62.0M | -32.9% |
| FY2016 | $92.5M | +49.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026